Technology Solutions

EQT VII acquires Certara for $850M

Wednesday, July 12, 2017

The EQT VII fund has agreed to acquire Certara, a provider of technology-driven decision support solutions for drug development, for an enterprise value of $850 million. The company is being acquired from Arsenal Capital Partners. As part of the transaction, Arsenal Capital Partners will retain a minority ownership stake in Certara, with the Company’s current management team, led by Edmundo Muniz, M.D., Ph.D., continuing to lead the organization, building on a multi-year track record of both organic growth and strategic acquisitions.

[Read More]

CRF Health, University Hospital Basel partner for multiple sclerosis clinical trials

Wednesday, July 12, 2017

CRF Health, a global provider of patient-centered eSource technology and service solutions for the life sciences industry, has collaborated with a research group led by Professor Ludwig Kappos at the University Hospital Basel (UHB) to develop an electronic implementation of the Neurostatus-Expanded Disability Status Scale (Neurostatus-EDSS), an established assessment and documentation tool for multiple sclerosis (MS) clinical trials.

[Read More]

GlaxoSmithKline and Exscientia enter strategic drug discovery collaboration

Thursday, July 6, 2017

Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, has entered into a strategic drug discovery collaboration with GlaxoSmithKline (GSK). During this collaboration, Exscientia will apply its AI-enabled platform and combine it with the expertise of GSK, in order to discover novel and selective small molecules for up to 10 disease-related targets, nominated by GSK across multiple therapeutic areas.

[Read More]

TriNetX launches OMOP common data model toolkit for data acquisition

Monday, July 3, 2017

TriNetX, a global health research network for healthcare organizations, biopharma and CROs, announced support for the Observational Medical Outcomes Partnership (OMOP) common data model. Combined with its support of i2b2 database sites, the addition of the OMOP toolkit expands the number of healthcare organizations who can join the TriNetX network with minimal IT investment.

[Read More]

Roche acquires mySugr to form digital diabetes management open platform

Friday, June 30, 2017

Roche and mySugr announced that the two partners have signed an agreement under which Roche acquired all shares of mySugr. Counting more than one million users globally, mySugr is one of the leading mobile diabetes platforms in the market and will become an integral part of Roche’s new patient-centered digital health services platform in diabetes care. The acquisition allows Roche to expand its leading position in the area of diabetes management.

[Read More]

inVentiv, Medidata partner to expand use of patient-centered technology

Wednesday, June 28, 2017

Medidata, a global provider of cloud-based technology and data analytics for clinical research, and inVentiv Health, a biopharmaceutical professional services company,  announced a multi-year partnership to bring patient-centric technology and leading clinical trial expertise to the biopharmaceutical industry. The partnership will broaden the reach of Medidata’s electronic informed consent (eConsent) technology, Medidata Enroll, to patients, sites and biopharmaceutical clients worldwide.

[Read More]

Carolinas Healthcare System selects Cerner’s Population Health Management Platform

Wednesday, June 28, 2017

Cerner, a global provider of healthcare technology, announced Carolinas HealthCare System (CHS) has chosen Cerner’s HealtheIntentSM population health management platform to coordinate and manage care for its more than 12 million patient interactions each year across its facilities and clinically integrated network, Carolinas Physician Alliance (CPA). CHS will continue to use the Cerner Millennium integrated electronic health record (EHR) and will also extend its remote hosting relationship with Cerner.

[Read More]

Median Technologies, Medidata partner on image management services

Tuesday, June 27, 2017

Medidata, a global provider of cloud-based solutions and data analytics for clinical research, and Median Technologies, the Imaging Phenomics Company, announced a new collaboration to streamline the growth and use of medical imaging in cancer clinical trials. Median Technologies will leverage the Medidata Clinical Cloud to accelerate the development of medicines in oncology with new, scalable image management services.

[Read More]

Baheal Group will bring IBM’s Watson for genomics to China

Monday, June 26, 2017

IBM Watson Health announced that Baheal Pharmaceutical Group will bring Watson for Genomics to clinicians across China. As IBM’s primary channel partner for Watson for Genomics in China, Baheal will establish an ecosystem within China to sell the molecular data interpretation technology to clinicians and researchers across the country. The new multi-year agreement comes less than three months after Baheal and IBM launched a strategic alliance to distribute Watson for Oncology in China.

[Read More]